Less than four months after…
Less than four months after rejecting Sentynl Therapeutics and Cyprium [...]
The twisting journey of Pretzel…
The twisting journey of Pretzel Therapeutics’ top brass appears to [...]
AbbVie has announced a deal with…
AbbVie has announced a deal with the White House to [...]
The J.P. Morgan Healthcare…
The J.P. Morgan Healthcare Conference is rolling on Tuesday with [...]
Lyra Therapeutics is abandoning…
Lyra Therapeutics is abandoning work on its rhinosinusitis treatment and [...]
Gary Gibbons, M.D., is retiring as…
Gary Gibbons, M.D., is retiring as National Heart, Lung and [...]
F.D.A. Decisions on Abortion Pill Were Based on Science, New Analysis Finds
A study of more than 5,000 pages of agency documents [...]
Already on track to achieve…
Already on track to achieve blockbuster status in its third [...]
With $10 billion pledged to beef…
With $10 billion pledged to beef up its U.S. operations [...]
A phase 3 rheumatoid arthritis…
A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 [...]